The AXP is a proprietary system used for the processing of stem cells from cord blood.
Melville Engle, CEO of ThermoGenesis, said: “We reviewed a number of potential bag set suppliers and selected ATEK based on their high level of expertise and strong track record of producing Six Sigma quality, state-of-the art disposables and medical devices.
“We are collaborating closely with ATEK on processes and procedures to ensure that we have access to high quality, reliable production as we continue to expand the market for the AXP. Moreover, with production occurring at ATEK’s FDA-approved, ISO 13485 certified facility we expect to achieve meaningful cost savings in the manufacturing of the product.
“With the addition of ATEK, we have easily doubled our suppliers’ capacity to produce bag sets, which is essential for our fiscal 2011 growth strategy. We have added several new AXP distributors who are complementing our strong relationship with GE Healthcare and addressing new markets in Asia and Europe. ATEK will facilitate our ability to meet what we believe will be a continuing increase in demand for the product.”
Dave Mabie, VP of business development at ATEK, said: “ATEK has significant experience with complex medical device manufacturing and is the only contract manufacturer of Class II and III finished medical devices and disposables in the country that was previously a medical device OEM. We are delighted to be working with ThermoGenesis and having the opportunity to demonstrate our ability to produce the highest quality medical device products in the market.”
